Lineage Cell Therapeutics (LCTX) Equity Income (2015 - 2025)
Lineage Cell Therapeutics (LCTX) reported Equity Income of -$7000.0 for Q4 2025, down 75.0% on a YoY basis from -$28000.0 in Q4 2024, and down 75.0% quarter-over-quarter from -$4000.0 in Q4 2024.
Lineage Cell Therapeutics (LCTX) Equity Income (2015 - 2025) Analysis & Trends
Lineage Cell Therapeutics has reported Equity Income for 9 years, with the latest figure at -$7000.0 in Q4 2025.
- For the quarter ending Q4 2025, Equity Income fell 75.0% year-over-year to -$7000.0; the trailing twelve-month figure through Mar 2026 stood at -$7000.0 (up 65.0% YoY), and the FY2025 full-year result was -$8000.0, changed 0.0% from the prior year.
- Equity Income for Q4 2025 stood at -$7000.0, down from -$4000.0 in the prior quarter.
- The five-year high for Equity Income was $40000.0 in Q1 2023, with the low at -$517000.0 in Q4 2022.
- Historically, Equity Income has averaged -$86666.7 across 4 years, with a median of -$7000.0 in 2025.
- Annual changes were most pronounced in 2023 — Equity Income surged 98.84% — and 2025, when it sank 75.0%.
- Lineage Cell Therapeutics' Equity Income stood at -$517000.0 in 2022, then surged by 98.84% to -$6000.0 in 2023, then jumped by 33.33% to -$4000.0 in 2024, then slumped by 75.0% to -$7000.0 in 2025.
- The last three Equity Income figures came in at -$7000.0 (Q4 2025), -$4000.0 (Q4 2024), and -$6000.0 (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7,000.00 |
| Dec 31, 2024 | -4,000.00 |
| Sep 30, 2024 | -6,000.00 |
| Jun 30, 2024 | -10,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | -37,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | -517,000.00 |
| Sep 30, 2022 | -233,000.00 |
| Jun 30, 2020 | 2.10 Mn |
| Sep 30, 2019 | -8.29 Mn |
| Jun 30, 2019 | -21.43 Mn |
| Mar 31, 2019 | 37.71 Mn |
| Dec 31, 2018 | 15,000.00 |
| Sep 30, 2018 | -15,000.00 |
| Jun 30, 2018 | 15,000.00 |
| Dec 31, 2016 | -3.48 Mn |
| Sep 30, 2016 | -855,000.00 |
| Jun 30, 2016 | -98,000.00 |
| Mar 31, 2016 | -235,000.00 |